  | Becker, G., Lespine, L.-F., Bahri, M. A., Serrano Navacerrada, M. E., Lemaire, C., Luxen, A., Tirelli, E., & Plenevaux, A. (2022). Exercise against cocaine sensitization in mice: a [18F]fallypride micro-PET study. Brain Communications, 4 (1), 294. doi:10.1093/braincomms/fcab294  Peer Reviewed verified by ORBi |
 | Salmon, E., Bahri, M. A., Plenevaux, A., Becker, G., Seret, A., Delhaye, E., Degueldre, C., Balteau, E., Lemaire, C., Luxen, A., & Bastin, C. (09 August 2021). In vivo exploration of synaptic projections in frontotemporal dementia. Scientific Reports, 11, 16092. doi:10.1038/s41598-021-95499-1 Peer Reviewed verified by ORBi |
 | Jacques, S., Arjomand, A., Perée, H., COLLINS, P., Mayer, A., Lavergne, A., Wéry, M., Mni, M., Hego, A., Thuillier, V., Becker, G., Bahri, M. A., Plenevaux, A., Di Valentin, E., Oury, C., MOUTSCHEN, M., Delvenne, P., Paquot, N., & Rahmouni, S. (2021). Dual‑specificity phosphatase 3 deletion promotes obesity, non‑alcoholic steatohepatitis and hepatocellular carcinoma. Scientific Reports, 11, 5817. doi:10.1038/s41598-021-85089-6 Peer Reviewed verified by ORBi |
  | Goutal, S., Guillermier, M., Becker, G., Gaudin, M., Bramoulle,, Y., Luxen, A., Lemaire, C., Plenevaux, A., SALMON, E., Hantraye, P., Barret, O., & Van Camp, N. (2021). The pharmacokinetics of [(18)F]UCB-H revisited in the healthy non-human primate brain. EJNMMI Res, 11 (1), 36. doi:10.1186/s13550-021-00777-8 Peer reviewed |
 | Becker, G., Michel, A., Bahri, M. A., Mairet-Coello, G., Lemaire, C., Deprez, T., Freyssin, A., Jacquin, L., Hustadt, F., De Wolf, C., Caruso, M., Frequin, J.-M., Gillent, E., Bezard, E., Garraux, G., Luxen, A., Citron, M., Downey, P., & Plenevaux, A. (2021). Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[ 18 F]fluoro-L-m-tyrosine imaging and motor performances analysis. Neurobiology of Aging, 107, 142-152. doi:10.1016/j.neurobiolaging.2021.07.012 Peer Reviewed verified by ORBi |
 | Becker, G., Dammicco, S., Bahri, M. A., & SALMON, E. (14 May 2020). The Rise of Synaptic Density PET Imaging. Molecules, 25, 2303. doi:10.3390/molecules25102303 Peer Reviewed verified by ORBi |
 | Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Germonpre, C., Lemaire, C., Giacomelli, F., Mievis, F., Luxen, A., Salmon, E., Rogister, B., Raedt, R., & Plenevaux, A. (2020). Exploring with [(18)F]UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy. Molecular Imaging and Biology. doi:10.1007/s11307-020-01488-7 Peer Reviewed verified by ORBi |
 | Salmon, E., Bahri, M. A., Plenevaux, A., Becker, G., Seret, A., Giacomelli, F., Delhaye, E., Degueldre, C., Balteau, E., Luxen, A., & Bastin, C. (2020). PET-[18F]UCB-H for assessing synaptic density in FTD. Alzheimer's and Dementia: the Journal of the Alzheimer's Association, 16 (S4), 037156. Peer Reviewed verified by ORBi |
 | Bastin, C.* , Bahri, M. A.* , Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (2020). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography. European Journal of Nuclear Medicine and Molecular Imaging, 47 (2), 390-402. doi:10.1007/s00259-019-04461-x Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Nagachinta, S., Becker, G., Dammicco, S., Serrano Navacerrada, M. E., LEROI, N., Bahri, M. A., Plenevaux, A., Lemaire, C., Lopez, R., Luxen, A., & de la Fuente, M. (2020). Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET. Colloids and Surfaces. B, Biointerfaces, 188, 110793. doi:10.1016/j.colsurfb.2020.110793 Peer Reviewed verified by ORBi |
 | Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Seret, A., Mestdagh, N., Mercier, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (01 May 2019). Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET. Molecules, 24 (9), 1705. doi:10.3390/molecules24091705 Peer Reviewed verified by ORBi |
Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Germonpré, C., Lemaire, C., Giacomelli, F., Mievis, F., Luxen, A., Salmon, E., Rogister, B., Raedt, R., & Plenevaux, A. (19 March 2019). Longitudinal in vivo evaluation of brain synaptic density with [18F]UCB-H through the different phases in the kainic acid rat model of temporal lobe epilepsy [Paper presentation]. 14th European Molecular Imaging Meeting, Glasgow, United Kingdom. |
 | Manos-Turvey, A., Becker, G., Francotte, P., Serrano Navacerrada, M. E., Luxen, A., Pirotte, B., Plenevaux, A., & Lemaire, C. (11 February 2019). Fully Automated Synthesis and Evaluation of [ 18 F]BPAM121: Potential of an AMPA Receptor Positive Allosteric Modulator as PET Radiotracer. ChemMedChem, 14 (7), 788-795. doi:10.1002/cmdc.201800816 Peer Reviewed verified by ORBi |
 | VOTTERO, G., MORFOISSE, F., Durré, T., Blacher, S., Becker, G., Bahri, M. A., Plenevaux, A., Noël, A., & NIZET, J.-L. (2019). Contralateral vascularized lymph node transfer : an optimized mouse model. Journal of Reconstructive Microsurgery Open, 4, 83-e91. Peer reviewed |
 | Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2019). Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value. Molecular Imaging and Biology, 21, 888-897. doi:10.1007/s11307-018-1301-0 Peer Reviewed verified by ORBi |
Bastin, C., Bahri, M. A., Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (28 November 2018). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography [Paper presentation]. Belgian Molecular Imaging Community conference 'Imaging hallmarks of disease progression & treatment response', Braine-L'Alleud, Belgium. |
Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., Salmon, E., Raedt, R., & Plenevaux, A. (18 October 2018). THE SV2A PROTEIN: IMAGING SYNAPTIC DENSITY DURING THE PROGRESSION OF THE TEMPORAL LOBE EPILEPSY IN THE KASE RAT MODEL [Poster presentation]. MINC 2018 – Multimodal Neuroimaging Cologne, Köln, Germany. |
 | Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20TH EURON PhD DAYS, Leuven, Belgium. |
 | Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20th EURON PhD days, Brussels, Belgium. |
 | Bodart, G., Farhat, K., Charlet-Renard, J. D. C., Becker, G., Plenevaux, A., Salvatori, R., Geenen, V., & Martens, H. (06 June 2018). The severe deficiency of the somatotrope GHRH/GH/IGF1 axis of Ghrh-/- mice is associated with an important splenic atrophy and relative B lymphopenia. Frontiers in Endocrinology, 9 (Art. 296). doi:10.3389/fendo.2018.00296 Peer Reviewed verified by ORBi |
Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., & Plenevaux, A. (22 March 2018). [18F]UCB-H BINDING QUANTIFICATION IN RAT BRAIN: FROM MODELLING TO SUV [Poster presentation]. 13th European Molecular Imaging Meeting - EMIM 2018, San Sebastián, Spain. |
Becker, G., Lespine, L.-F., Bahri, M. A., Bruneel, J., Serrano Navacerrada, M. E., Luxen, A., Tirelli, E., & Plenevaux, A. (March 2018). Increased hippocampal volume in exercising mice: comparison of control conditions with in vivo voxel based morphometry [Poster presentation]. European Molecular Imaging Meeting - EMIM 2018, San Sebastian, Spain. |
 | Goux, M., Becker, G., Gorre, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., LALLEMAND, F., Bahri, M. A., Doumont, G., Plenevaux, A., Cinier, M., & Luxen, A. (19 January 2018). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors [Paper presentation]. 25th NKRV Workshop, Maastricht, Netherlands. |
Becker, G. (2018). Presentation of the GIGA - Cyclotron Research Center [Paper presentation]. 25th NKRV Workshop. |
 | Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (December 2017). Sv2a protein levels in the kainic acid epilepsy rat model during the acute phase. Epilepsia, 58 (Supplement S5), 1–S225. |
 | Bahri, M. A., Plenevaux, A., Aerts, J., Bastin, C., Becker, G., Mercier, J., Valade, A., Buchanan, T., Mestdagh, N., LEDOUX, D., Seret, A., Luxen, A., & Salmon, E. (November 2017). Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 4 (4), 481-486. doi:10.1016/j.trci.2017.08.004 Peer Reviewed verified by ORBi |
 | Goux, M., Becker, G., Gorré, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., Lallemand, F., Bahri, M. A., Doumont, G., Plenevaux, A., Cinier, M., & Luxen, A. (21 August 2017). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of 2 Epidermal Growth Factor Receptor Over-Expressing Tumors. Bioconjugate Chemistry, 28 (9), 2361-2371. doi:10.1021/acs.bioconjchem.7b00374 Peer Reviewed verified by ORBi |
 | Dammicco, S., Goux, M., Lemaire, C., Becker, G., Bahri, M. A., Plenevaux, A., Cinier, M., & Luxen, A. (2017). Regiospecific radiolabelling of Nanofitin on Ni Magnetic Beads with [18F]FBEM and in vivo PET studies. Nuclear Medicine and Biology. doi:10.1016/j.nucmedbio.2017.04.006 Peer Reviewed verified by ORBi |
 | Manos-Turvey, A., Lemaire, C., Becker, G., Plenevaux, A., Luxen, A., Pirotte, B., & Francotte, P. (August 2017). Design and Synthesis of [18F]BPAM121, a PET-Probe Targeting AMPA-subtype Glutamatergic Receptors [Poster presentation]. EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry, Vienne, Austria. |
Manos-Turvey, A., Lemaire, C., Becker, G., Plenevaux, A., Luxen, A., Francotte, P., & Pirotte, B. (July 2017). Synthesis of [18F]BPAM121: An AMPAR Modulator with Potential as a PET Probe [Poster presentation]. RICT 2017, Drug Discovery and Selection, 53rd International Conference on Medicinal Chemistry, Toulouse, France. |
 | Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (26 June 2017). Pharmacokinetic characterization of [18F]UCB-H PET radiopharmaceutical in the rat brain. Molecular Pharmaceutics, 14 (8), 2719-2725. doi:10.1021/acs.molpharmaceut.7b00235 Peer Reviewed verified by ORBi |
 | Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (10 June 2017). Evaluation of dopaminergic terminal loss in a Parkinson's disease rat model, [18F]FDOPA versus [18F]FMT microPET [Paper presentation]. SNMMI 2017 Annual Meeting, Denver, United States. |
 | Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (May 2017). Comparative assessment of 6-[18F]fluoro-L-m-tyrosine and 6-[18F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson’s disease rat model. Journal of Neurochemistry, 141, 626-635. doi:10.1111/jnc.14016 Peer Reviewed verified by ORBi |
 | Becker, G., Lespine, L.-F., Bahri, M. A., Luxen, A., Lemaire, C., Tirelli, E., & Plenevaux, A. (05 April 2017). Functional correlates of the protective effects of free wheel-running against cocaine psychomotor sensitization on dopamine D2 receptors: a [18F]Fallypride microPET study [Paper presentation]. European Molecular Imaging Meeting - EMIM 2017, Cologne, Germany. |
Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Luxen, A., Lemaire, C., Salmon, E., & Plenevaux, A. (19 February 2017). Noninvasive quantification of [18F]UCB-H binding using microPET and population-based input function [Poster presentation]. Neuroimaging - from Molecules to Networks - TOPIM 2017, Les Houches, France. |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (01 February 2017). Evaluating the specificity of [18F] UCB-H for the isoform SV2A, compared with isoforms SV2B and SV2C [Poster presentation]. GIGA Day 2017, Liège, Belgium. |
Becker, G. (2017). Preclinical imaging: a tool for translational research [Paper presentation]. GIGA Day 2017. |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). [18F]UCB-H RADIOTRACER AS A TOOL TO UNDERSTAND THE ROLE OF THE SV2A PROTEIN [Poster presentation]. PhD Student Day, Liège, Belgium. |
Becker, G., Lespine, L.-F., Serrano Navacerrada, M. E., Bahri, M. A., Luxen, A., Lemaire, C., Tirelli, E., & Plenevaux, A. (2017). Neuro-functional correlates of the protective effects of exercise against cocaine sensitization and dopamine D2 receptors density: a [18F]Fallypride microPET study [Paper presentation]. World Molecular Imaging Congress - WMIC 2017, Philadelphia, United States. |
 | Salmon, E., Bahri, M. A., Manard, M., Plenevaux, A., Becker, G., Seret, A., Mella, C., Aerts, J., Giacomelli, F., Luxen, A., & Bastin, C. (2017). Decreased Synaptic Density in Early Alzheimer’s Disease Assessed with [18F]UCB-H-PET [Paper presentation]. Alzheimer Association International Conference 2017. Peer reviewed |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN THE KAINIC ACID EPILEPSY RAT MODEL [Poster presentation]. 12th European Molecular Imaging Meeting (EMIM 2017), Cologne, Germany. |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN AN EPILEPTIC RAT MODEL [Poster presentation]. 3rd Belgium Molecular Imaging Congress (BMIC 2017), Brussels, Belgium. |
Serrano Navacerrada, M. E., Aerts, J., Bahri, M. A., Becker, G., Giacomelli, F., Lemaire, C., Luxen, A., Mercier, J., Mestdagh, N., Mievis, F., Plenevaux, A., Salmon, E., & Warnier, C. (18 November 2016). EVALUATING THE SPECIFICITY OF [18F]UCB-H FOR THE ISOFORM SV2A, COMPARED WITH ISOFORMS SV2B AND SV2C [Poster presentation]. MedChem 2016 PET & Imaging : From Chemistry Lab to Clinical Applications, Mont-Saint-Guibert, Belgium. |
| Bartholomé, O., Van Den Ackerveken, P., Wislet, S., Leprince, P., Rogister, B., MENTEN, C. (Other coll.), Serrano Navacerrada, M. E. (Other coll.), Neirincks, V. (Other coll.), Becker, G. (Other coll.), & Plainevaux, A. (Other coll.). (October 2016). Study of the SV2A protein role in Epilepsy [Poster presentation]. Congrès Automnal de la Belgian Society for Cell and Developmental Biology (BSCDB). |
 | Warnier, C., Lemaire, C., Becker, G., Zaragoza, G., Giacomelli, F., Aerts, J., Otabashi, M., Bahri, M. A., Mercier, J., Plenevaux, A., & Luxen, A. (06 September 2016). Enabling efficient PET imaging of Synaptic Vesicle glycoprotein 2A (SV2A) with a robust and one-step radiosynthesis of a highly potent 18F-labelled ligand ([18F]UCB-H). Journal of Medicinal Chemistry, 59, 8955-8966. doi:10.1021/acs.jmedchem.6b00905 Peer Reviewed verified by ORBi |
 | Gijs, M., Becker, G., Plenevaux, A., Bahri, M. A., Aerts, A., Impens, N., Baatout, S., & Luxen, A. (11 August 2016). Biodistribution of Novel 68Ga-Radiolabelled HER2 Aptamers in Mice. Journal of Nuclear Medicine and Radiation Therapy, 7 (5). doi:10.4172/2155-9619.1000300 Peer reviewed |
Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Luxen, A., Garraux, G., Lemaire, C., & Plenevaux, A. (July 2016). In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat model: comparison between [18F]FMT and [18F]FDOPA [Paper presentation]. World Molecular Imaging Congress 2015, Honolulu, United States. |
Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (09 March 2016). EVALUATION OF SV2Alox/Cre TRANSGENIC MICE USING [18F]UCB-H IN VITRO AUTORADIOGRAPHY [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands. |
 | Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Luxen, A., Garraux, G., Lemaire, C., & Plenevaux, A. (08 March 2016). In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat with AAV-induced overexpression of alpha-synuclein: a [18F]FMT microPET study [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands. |
 | Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Luxen, A., Lemaire, C., Salmon, E., & Plenevaux, A. (08 March 2016). In vivo evaluation of [18F]UCB-H binding at SV2A protein, through a new and efficient radiosynthesis of [18F]UCB-H [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands. |
Bodart, G., Farhat, K., RENARD, J. D. C., Becker, G., Plenevaux, A., Martens, H., Salvatori, R., & Geenen, V. (25 January 2016). Disturbed dexamethasone-induced thymus atrophy and recovery in Ghrh-/- mice with severe deficiency of the somatotrope GHRH/GH/IGF-1 axis [Paper presentation]. GIGA-Day 2016, Liège, Belgium. |
 | MENTEN, C.* , Serrano Navacerrada, M. E.* , Bartholomé, O., Gil, J. S., Neirinckx, V., Wislet, S., Becker, G., Plenevaux, A., Van Den Ackerveken, P.* , & Rogister, B.*. (2016). Development and validation of a new mouse model to investigate the role of sv2a in epilepsy. PLoS ONE. doi:10.1371/journal.pone.0166525 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Yankam Njiwa, J., Costes, N., Bouillot, C., Bouvard, S., Fieux, S., Becker, G., Levigoureux, E., Kocevar, G., Stamile, J., Langlois, J.-B., Bolbos, R., Bonnet, C., Bezin, L., Zimmer, L., & Hammers, A. (2016). Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [11C]-(R)-PK11195 PET and MRI. Journal of Cerebral Blood Flow and Metabolism. Peer Reviewed verified by ORBi |
 | Becker, G., Bolbos, R., Costes, N., Redouté, J., Newman-Tancredi, A., & Zimmer, L. (2016). Selective serotonin 5-HT1A receptor biased agonists elicit distinct brain activation patterns: a pharmacoMRI study. Scientific Reports. Peer Reviewed verified by ORBi |
Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (04 September 2015). EVALUATION OF SV2Alox/Cre TRANSGENIC MOUSE USING [18F]UCB-H IN IN VITRO AUTORADIOGRAPHY [Poster presentation]. International Symposium "Aging and sleep: Perks for longevity?, Liège, Belgium. |
Seret, A., Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (09 May 2015). [18F]FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model [Poster presentation]. 17th Symposium of the Belgian Society of Nuclear Medicine, Maastricht, Netherlands. |
 | Goux, M., Dammicco, S. (Other coll.), Becker, G. (Other coll.), Bahri, M. A. (Other coll.), Plenevaux, A. (Other coll.), & Luxen, A. (Other coll.). (May 2015). Strategies of regioselective radiolabeling of Nanofitin binder for imaging [Poster presentation]. BioForum 2015, Liège, Belgium. |
Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Lemaire, C., & Plenevaux, A. (18 March 2015). 18F-FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model [Poster presentation]. European Molecular Imaging Meeting EMIM 2015, Tübingen, Germany. |
| Moës, F., Plenevaux, A., Becker, G., Tirelli, E., & Lespine, L.-F. (27 January 2015). Exploration of volumetric cerebral changes, with de micro-MRi, due to psychomotor exercise in mice [Poster presentation]. GIGA day, Liège, Belgium. |
 | Becker, G., Streichenberger, N., Billard, T., Newman-Tancredi, A., & Zimmer, L. (2014). A Postmortem Study to Compare Agonist and Antagonist 5-HT1A Receptor-binding Sites in Alzheimer’s Disease Guillaume. CNS: Neuroscience and Therapeutics, 20. Peer Reviewed verified by ORBi |
 | Becker, G., Collomb, J., Sgambato-Faure, V., Tremblay, L., Billard, T., & Zimmer, L. (2014). Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-014-2936-y Peer Reviewed verified by ORBi |
 | Collomb, J., Becker, G., Fieux, S., Zimmer, L., & Billard, T. (2014). Syntheses, Radiolabelings, and in Vitro Evaluations of Fluorinated PET Radioligands of 5‑HT6 Serotoninergic Receptors. Journal of Medicinal Chemistry. Peer Reviewed verified by ORBi |
 | Colomb, J., Becker, G., Forcellini, E., Meyer, S., Buisson, L., Zimmer, L., & Billard, T. (2014). Synthesis and pharmacological evaluation of a new series of radiolabeled ligands for 5-HT7 receptor PET neuroimaging. Nuclear Medicine and Biology. doi:10.1016/j.nucmedbio.2014.01.008 Peer Reviewed verified by ORBi |
Becker, G., Collomb, J., Billard, T., & Zimmer, L. (2013). Radiosynthesis and radiopharmacological evaluation of fluorinated PET radioligands for the 5-HT6 receptors [Paper presentation]. Society of Nuclear Medicine and Molecular Imaging Annual Meeting. |
Becker, G. (2013). Towards functional TEP imaging of 5HT1A receptors [Paper presentation]. Colloque SCMC 2013. |
Collomb, J., Becker, G., Zimmer, L., & Billard. (2013). Synthesis and evaluation of potential PET 18F- radioligands for the 5-HT6 receptor [Poster presentation]. 20th International Symposium on Radiopharmaceutical Sciences. |
Becker, G. (2013). Radiosynthesis and radiopharmacological evaluation of fluorinated PET radioligands for the 5-HT6 receptors [Poster presentation]. European Molecular Imaging Meeting. |
 | Da Costa Branquinho, E., Becker, G., Bouteiller, C., Jean, L., Renard, P.-Y., & Zimmer, L. (2013). Radiosynthesis and in vivo evaluation of fluorinated huprine derivates as PET radiotracers of acetylcholinesterase. Nuclear Medicine and Biology. doi:10.1016/j.nucmedbio.2013.02.004 Peer Reviewed verified by ORBi |
Becker, G., Streichenberger, N., Billard, T., Vacher, B., Newman-Tancredi, A., & Zimmer, L. (2013). post-mortem study to compare the 5-HT1A receptor binding of a PET agonist and a PET antagonist in Alzheimer’s disease [Paper presentation]. EANM'13 Annual Congress of the European Association of Nuclear Medicine. |
Tavares, A., Becker, G., Barret, O., Morley, T., Alagille, D., Vacher, B., Newman-Tancredi, A., Tamagnan, G., & Zimmer, L. (2013). Initial evaluation of [18F]F13714, a novel 5-HT1A receptor agonist in non-human primates [Paper presentation]. EANM'13 Annual Congress of the European Association of Nuclear Medicine. |
Becker, G., Collomb, J., Billard, T., & Zimmer, L. (2013). Preclinical evaluation of serotonin 5-HT6 receptor radioligands for PET imaging [Paper presentation]. EANM'13 Annual Congress of the European Association of Nuclear Medicine. |
 | Lemoine, L., Becker, G., Vacher, B., Billard, T., Lancelot, S., Newman-Tancredi, A., & Zimmer, L. (June 2012). Radiosynthesis and Preclinical Evaluation of 18F-F13714 as a Fluorinated 5-HT1A Receptor Agonist Radioligand for PET Neuroimaging. Journal of Nuclear Medicine, 53. doi:10.2967/jnumed.111.101212 Peer Reviewed verified by ORBi |
Lemoine, L., Collomb, J., Becker, G., Liger, F., Le Bars, D., Zimmer, L., & Billard, T. (2011). 19th International Symposium on Radiopharmaceutical Sciences [Poster presentation]. Design, labelling and first radiopharmacological evaluations of novel 5HT7 receptor radioligands. |
Collomb, J., Becker, G., Le Bars, D., Zimmer, L., & Billard, T. (2011). Synthesis and biological evaluation of 18F radiolabeled 5HT7 receptor ligands for medical imaging [Poster presentation]. 47th International Conference on Medicinal Chemistry. |